Product Information
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2208 per EA under NDC 68180084313. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 23, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180084313
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091440FDA Approved
10/23/2012
TE Code
AB
On Market Since
10/24/2012
Price Statistics
The NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 76.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2208 per EA |
|---|---|
| All-time high | $0.9955 (Apr 13, 2016) |
| All-time low | $0.1058 (Nov 20, 2024) |
| 52-week high | $0.2208 |
| 52-week low | $0.1515 |
| Median price | $0.2980 |
| Average price | $0.4270 |
| Largest weekly change | +55.0% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2208 per EA (NDC 68180084313), effective Aug 19, 2026.
How has the price of LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has declined 76.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
Since Nov 28, 2013, the NADAC for LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET has ranged from a low of $0.1058 (Nov 20, 2024) to a high of $0.9955 (Apr 13, 2016), with a median of $0.2980 per EA.
Are there cheaper alternatives to LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 49% below LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET.
Who manufactures LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET?
LEVONORGESTREL-ETH ESTRAD 0.15 MG-0.03 MG TABLET (NDC 68180084313) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.